Title:
CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME
Document Type and Number:
WIPO Patent Application WO/2022/216811
Kind Code:
A3
Abstract:
Provided herein, among other things, are anti-CD19 chimeric antigen receptor (CAR)s and natural killer cells expressing the same.
Inventors:
KIM YUSUN (KR)
CHO SUNGYOO (KR)
HWANG YU KYEONG (KR)
FLYNN PETER (US)
LITTEN JASON B (US)
FARRELL THOMAS JAMES (US)
LIM JOHN KIN CHUAN (US)
CHO SUNGYOO (KR)
HWANG YU KYEONG (KR)
FLYNN PETER (US)
LITTEN JASON B (US)
FARRELL THOMAS JAMES (US)
LIM JOHN KIN CHUAN (US)
Application Number:
PCT/US2022/023654
Publication Date:
December 01, 2022
Filing Date:
April 06, 2022
Export Citation:
Assignee:
ARTIVA BIOTHERAPEUTICS INC (US)
GC CELL CORP (KR)
GC CELL CORP (KR)
International Classes:
A61K38/17; C07K14/705; C07K16/28
Domestic Patent References:
| WO2015095895A1 | 2015-06-25 | |||
| WO2020069409A1 | 2020-04-02 |
Foreign References:
| CN105925536A | 2016-09-07 |
Attorney, Agent or Firm:
HYMA, Katie et al. (US)
Download PDF: